Histological and molecular types of breast cancer: is there a unifying taxonomy? (original) (raw)
Reis-Filho, J. S. & Lakhani, S. R. Breast cancer special types: why bother? J. Pathol.216, 394–398 (2008). ArticleCASPubMed Google Scholar
Simpson, P. T., Reis-Filho, J. S., Gale, T. & Lakhani, S. R. Molecular evolution of breast cancer. J. Pathol.205, 248–254 (2005). ArticleCASPubMed Google Scholar
Vargo-Gogola, T. & Rosen, J. M. Modelling breast cancer: one size does not fit all. Nat. Rev. Cancer7, 659–672 (2007). ArticleCASPubMed Google Scholar
Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA98, 10869–10874 (2001). ArticleCASPubMedPubMed Central Google Scholar
Sorlie, T. et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl Acad. Sci. USA100, 8418–8423 (2003). ArticleCASPubMedPubMed Central Google Scholar
Scarff, R. W. & Torloni, H. Histological Typing of Breast Tumours (WHO, Geneva, 1968). Google Scholar
Azzopardi, J. G., Ahmed, A. & Millis, R. R. Problems in Breast Pathology (W. B. Saunders Company Ltd, London, 1979). Google Scholar
Azzopardi, J. G. et al. The World Health Organization histological typing of breast tumors: second edition. The World Health Organization. Am. J. Clin. Pathol.78, 806–816 (1982). Article Google Scholar
Huvos, A. G., Lucas, J. C. Jr & Foote, F. W. Jr. Metaplastic breast carcinoma: rare form of mammary cancer. NY State J. Med.73, 1078–1082 (1973). CAS Google Scholar
Tavassoli, F. A. Pathology of the Breast (Appleton & Lange, Stamford, 1999). Google Scholar
Rosen, P. P. Rosen's Breast Pathology (Lippincott Williams & Wilkins, Philadelphia, 2001). Google Scholar
Page, D. L. & Anderson, T. J. Diagnostic Histopathology of the Breast (Churchill Livingstone, Edinburgh, 1987). Google Scholar
Elston, C. W. & Ellis, I. O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology19, 403–410 (1991). ArticleCASPubMed Google Scholar
Ellis, I. O. et al. Pathological prognostic factors in breast cancer. II. Histological type: relationship with survival in a large study with long-term follow-up. Histopathology20, 479–489 (1992). ArticleCASPubMed Google Scholar
Longacre, T. A. et al. Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Mod. Pathol.19, 195–207 (2006). ArticlePubMed Google Scholar
Rakha, E. A. et al. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. J. Clin. Oncol.26, 3153–3158 (2008). ArticlePubMed Google Scholar
Habel, L. A. et al. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res.8, R25 (2006). ArticleCASPubMedPubMed Central Google Scholar
van de Vijver, M. J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med.347, 1999–2009 (2002). ArticleCASPubMed Google Scholar
Sotiriou, C. et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J. Natl Cancer Inst.98, 262–272 (2006). ArticleCASPubMed Google Scholar
Ellis, P. et al. in WHO Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs (eds Tavassoli, F. A. & Devilee, P) 13–59 (Lyon Press, Lyon, 2003). Google Scholar
Rakha, E. A. et al. Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast. Breast Cancer Res. Treat111, 121–127 (2008). ArticlePubMed Google Scholar
Wang, Y. et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet365, 671–679 (2005). ArticleCASPubMed Google Scholar
van 't Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature415, 530–536 (2002). ArticleCASPubMed Google Scholar
Wirapati, P. et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res.10, R65 (2008). ArticleCASPubMedPubMed Central Google Scholar
Geyer, F. C. & Reis-Filho, J. S. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet? Int. J. Surg. Pathol.17, 285–302 (2008). Article Google Scholar
Farmer, P. et al. Identification of molecular apocrine breast tumours by microarray analysis. Oncogene24, 4660–4671 (2005). ArticleCASPubMed Google Scholar
Abdullah-Sayani, A., Bueno- de-Mesquita, J. M. & van de Vijver, M. J. Technology Insight: tuning into the genetic orchestra using microarrays: limitations of DNA microarrays in clinical practice. Nat. Clin. Pract. Oncol.3, 501–516 (2006). ArticleCASPubMed Google Scholar
Rosen, P. P. & Oberman, H. A. Tumors of the Mammary Gland (Armed Forces Institute of Pathology, Washington, DC, 1993). Google Scholar
Tavassoli, F. A. Classification of metaplastic carcinomas of the breast. Pathol. Annu.27 (Pt 2), 89–119 (1992). PubMed Google Scholar
Sakamoto, G. Histological classification of breast cancer [Japanese]. Gan No Rinsho (May Suppl.), 105–113 (1985).
Sakamoto, G. Histological classification of breast cancer: 2 [Japanese]. Gan No Rinsho (Jan Suppl.), 197–204 (1986).
Eusebi, V., Damiani, S., Ellis, I. O., Azzopardi, J. G. & Rosai J. Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: report of 5 cases. Am. J. Surg. Pathol.27, 1114–1118 (2003). ArticleCASPubMed Google Scholar
Asioli, S. et al. Polymorphous adenocarcinoma of the breast: report of three cases. Virchows Arch.448, 29–34 (2006). ArticlePubMed Google Scholar
Collins, L. C. et al. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am. J. Surg. Pathol.30, 1002–1007 (2006). ArticlePubMed Google Scholar
Mulligan, A. M. & O'Malley, F. P. Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases. Int. J. Surg. Pathol.15, 143–147 (2007). ArticlePubMed Google Scholar
Leibl, S. & Moinfar, F. Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation. Am. J. Surg. Pathol.30, 450–456 (2006). ArticlePubMed Google Scholar
Wellings, S. R. & Jensen, H. M. On the origin and progression of ductal carcinoma in the human breast. J. Natl Cancer Inst.50, 1111–1118 (1973). ArticleCASPubMed Google Scholar
Wellings, S. R., Jensen, H. M. & Marcum, R. G. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J. Natl Cancer Inst.55, 231–273 (1975). CASPubMed Google Scholar
Potti, A. et al. Genomic signatures to guide the use of chemotherapeutics. Nat. Med.12, 1294–1300 (2006). ArticleCASPubMed Google Scholar
Peppercorn, J., Perou, C. M. & Carey, L. A. Molecular subtypes in breast cancer evaluation and management: divide and conquer. Cancer Invest.26, 1–10 (2008). ArticleCASPubMed Google Scholar
Gusterson, B. Do 'basal-like' breast cancers really exist? Nat. Rev. Cancer9, 128–134 (2009). ArticleCASPubMed Google Scholar
Moinfar, F. Is 'basal-like' carcinoma of the breast a distinct clinicopathological entity? A critical review with cautionary notes. Pathobiology75, 119–131 (2008). ArticleCASPubMed Google Scholar
Rakha, E. A. et al. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J. Pathol.208, 495–506 (2006). ArticleCASPubMed Google Scholar
Livasy, C. A. et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod. Pathol.19, 264–271 (2006). ArticleCASPubMed Google Scholar
Rouzier, R. et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin. Cancer Res.11, 5678–5685 (2005). ArticleCASPubMed Google Scholar
Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol.27, 1160–1167 (2009). ArticlePubMedPubMed Central Google Scholar
Doane, A. S. et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene25, 3994–4008 (2006). ArticleCASPubMed Google Scholar
Weigelt, B. et al. Refinement of breast cancer classification by molecular characterization of histological special types. J. Pathol.216, 141–150 (2008). ArticleCASPubMed Google Scholar
Lien, H. C. et al. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. Oncogene26, 7859–7871 (2007). ArticleCASPubMed Google Scholar
Bertucci, F. et al. Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Oncogene27, 5359–5372 (2008). ArticleCASPubMedPubMed Central Google Scholar
Zhao, H. et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol. Biol. Cell15, 2523–2536 (2004). ArticleCASPubMedPubMed Central Google Scholar
Korkola, J. E. et al. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res.63, 7167–7175 (2003). CASPubMed Google Scholar
Weigelt, B., Kreike, B. & Reis-Filho, J. S. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis. Breast Cancer Res. Treat.117, 273–280 (2008). ArticleCASPubMed Google Scholar
Bertucci, F. et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res.66, 4636–4644 (2006). ArticleCASPubMed Google Scholar
Jacquemier, J. et al. Typical medullary breast carcinomas have a basal/myoepithelial phenotype. J. Pathol.207, 260–268 (2005). ArticleCASPubMed Google Scholar
Vincent-Salomon, A. et al. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res.9, R24 (2007). ArticleCASPubMedPubMed Central Google Scholar
Azoulay, S. et al. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod. Pathol.18, 1623–1631 (2005). ArticleCASPubMed Google Scholar
Reis-Filho, J. S. et al. Metaplastic breast carcinomas are basal-like tumours. Histopathology49, 10–21 (2006). ArticleCASPubMed Google Scholar
Hayes, M. J., Thomas, D., Emmons, A., Giordano, T. J. & Kleer, C. G. Genetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast. Clin. Cancer Res.14, 4038–4044 (2008). ArticleCASPubMedPubMed Central Google Scholar
Stingl, J. & Caldas, C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat. Rev. Cancer7, 791–799 (2007). ArticleCASPubMed Google Scholar
Dontu, G., El-Ashry, D. & Wicha, M. S. Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol. Metab.15, 193–197 (2004). ArticleCASPubMed Google Scholar
Behbod, F. & Rosen, J. M. Will cancer stem cells provide new therapeutic targets? Carcinogenesis26, 703–711 (2005). ArticleCASPubMed Google Scholar
Hosey, A. M. et al. Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. J. Natl Cancer Inst.99, 1683–1694 (2007). ArticleCASPubMed Google Scholar
Liu, X. et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc. Natl Acad. Sci. USA104, 12111–12116 (2007). ArticleCASPubMedPubMed Central Google Scholar
McCarthy, A. et al. A mouse model of basal-like breast carcinoma with metaplastic elements. J. Pathol.211, 389–398 (2007). ArticleCASPubMed Google Scholar
Tognon, C. et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell2, 367–376 (2002). ArticleCASPubMed Google Scholar
Marchio, C. et al. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast. J. Pathol.215, 398–410 (2008). ArticleCASPubMed Google Scholar
Letessier, A. et al. ETV6 gene rearrangements in invasive breast carcinoma. Genes Chromosomes Cancer44, 103–108 (2005). ArticleCASPubMed Google Scholar
Makretsov, N. et al. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma. Genes Chromosomes Cancer40, 152–157 (2004). ArticleCASPubMed Google Scholar
Reis-Filho, J. S. et al. Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6 'split apart' probes. Histopathology52, 840–846 (2008). ArticleCASPubMed Google Scholar
Nassar, H. Carcinomas with micropapillary morphology: clinical significance and current concepts. Adv. Anat. Pathol.11, 297–303 (2004). ArticlePubMed Google Scholar
Thor, A. D. et al. Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization. Hum. Pathol.33, 628–631 (2002). ArticleCASPubMed Google Scholar
Hanby, A. M. & Hughes, T. A. In situ and invasive lobular neoplasia of the breast. Histopathology52, 58–66 (2008). ArticleCASPubMed Google Scholar
Mathieu, M. C. et al. The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur. J. Cancer40, 342–351 (2004). ArticlePubMed Google Scholar
Vos, C. B. et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br. J. Cancer76, 1131–1133 (1997). ArticleCASPubMedPubMed Central Google Scholar
Droufakou, S. et al. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int. J. Cancer92, 404–408 (2001). ArticleCASPubMed Google Scholar
Sarrio, D. et al. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int. J. Cancer106, 208–215 (2003). ArticleCASPubMed Google Scholar
Derksen, P. W. et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell10, 437–449 (2006). ArticleCASPubMed Google Scholar
Reis-Filho, J. S. et al. EGFR amplification and lack of activating mutations in metaplastic breast carcinomas. J. Pathol.209, 445–453 (2006). ArticleCASPubMed Google Scholar
Leibl, S., Gogg-Kammerer, M., Sommersacher, A., Denk, H. & Moinfar, F. Metaplastic breast carcinomas: are they of myoepithelial differentiation? Immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. Am. J. Surg. Pathol.29, 347–353 (2005). ArticlePubMed Google Scholar
Leibl, S. & Moinfar, F. Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors? J. Clin. Pathol.58, 700–704 (2005). ArticleCASPubMedPubMed Central Google Scholar
Turner, N. C. et al. BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene26, 2126–2132 (2007). ArticleCASPubMed Google Scholar
Turner, N. C. & Reis-Filho, J. S. Basal-like breast cancer and the BRCA1 phenotype. Oncogene25, 5846–5853 (2006). ArticleCASPubMed Google Scholar
Lien, H. C. et al. p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components. J. Pathol.204, 131–139 (2004). ArticleCASPubMed Google Scholar
Simpson, P. T. et al. Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am. J. Surg. Pathol.29, 734–746 (2005). ArticlePubMed Google Scholar
Abdel-Fatah, T. M. et al. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am. J. Surg. Pathol.31, 417–426 (2007). ArticlePubMed Google Scholar
Abdel-Fatah, T. M. et al. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am. J. Surg. Pathol.32, 513–523 (2008). ArticlePubMed Google Scholar
Chin, K. et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell10, 529–541 (2006). ArticleCASPubMed Google Scholar
Natrajan, R. et al. Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin. Cancer Res.15, 2711–2722 (2009). ArticleCASPubMed Google Scholar
Marchio, C. et al. Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components. J. Pathol.218, 301–315 (2009). ArticleCASPubMed Google Scholar
Slamon, D. J. et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science235, 177–182 (1987). ArticleCASPubMed Google Scholar
Bernard-Pierrot, I. et al. Characterization of the recurrent 8p11–12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res.68, 7165–7175 (2008). ArticleCASPubMed Google Scholar
Reis-Filho, J. S. et al. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin. Cancer Res.12, 6652–6662 (2006). ArticleCASPubMed Google Scholar
Cuny, M. et al. Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations. Cancer Res.60, 1077–1083 (2000). CASPubMed Google Scholar
Elbauomy Elsheikh, S. et al. FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis. Breast Cancer Res.9, R23 (2007). ArticleCASPubMedPubMed Central Google Scholar
Hennessy, B. T. et al. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann. Oncol.17, 605–613 (2006). ArticleCASPubMed Google Scholar
Ashworth, A. A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair. J. Clin. Oncol.26, 3785–3790 (2008). ArticleCASPubMed Google Scholar
Flagiello, D. et al. Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer. Genes Chromosomes Cancer23, 300–306 (1998). ArticleCASPubMed Google Scholar
Calza, S. et al. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res.8, R34 (2006). ArticleCASPubMedPubMed Central Google Scholar
Fan, C. et al. Concordance among gene-expression-based predictors for breast cancer. N. Engl. J. Med.355, 560–569 (2006). ArticleCASPubMed Google Scholar
Rody, A. et al. The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial. Breast16, 235–240 (2007). ArticleCASPubMed Google Scholar